Of note, 1 patient with psoriatic arthritis who developed myelitis due to MOGAD (MOG-IgG 1:1,000 by live CBA) was receiving the anti–tumor necrosis factor (TNF)-α agent adalimumab. Here, MOG is linked to myelitis.